Drug and Device MDL Update


Several years ago, we decided to try to name the drug and device mass torts.   You know, in case the longest-running products liability MDL is ever the Final Jeopardy answer.  Or, if knowing the largest pharmaceutical MDL to date is something you can use as an ice breaker.  Actually, if you know those things, as my grandmother would say – that and a nickel will get you a cup of coffee (she’s 95 and unfamiliar with Starbuck’s prices).

But, we decided the list was worth updating anyway – including providing links to litigation websites where available.  Let’s start with the ones that are still around since our original post in 2008.  Some are shadows of their former selves; just a few cases hanging on for resolution:

MDL - 986 IN RE: "Factor VIII or IX Concentrate Blood Products" Products Liability Litigation (no website)

MDL-1203 IN RE Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Products Liability Litigation

MDL-1431 IN RE Baycol Products Liability Litigation

MDL-1596 IN RE Zyprexa Products Liability Litigation (no website)

MDL-1626 IN RE Accutane Products Liability Litigation (no website)

MDL-1629 IN RE Neurontin Marketing, Sales Practices and Products Liability Litigation (no website)

Please see full update below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Dechert LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.